Skip to Content
Merck
  • Small molecule-triggered Cas9 protein with improved genome-editing specificity.

Small molecule-triggered Cas9 protein with improved genome-editing specificity.

Nature chemical biology (2015-04-08)
Kevin M Davis, Vikram Pattanayak, David B Thompson, John A Zuris, David R Liu
ABSTRACT

Directly modulating the activity of genome-editing proteins has the potential to increase their specificity by reducing activity following target locus modification. We developed Cas9 nucleases that are activated by the presence of a cell-permeable small molecule by inserting an evolved 4-hydroxytamoxifen-responsive intein at specific positions in Cas9. In human cells, conditionally active Cas9s modify target genomic sites with up to 25-fold higher specificity than wild-type Cas9.

MATERIALS
Product Number
Brand
Product Description

Sigma-Aldrich
(Z)-4-Hydroxytamoxifen, ≥98% Z isomer
Supelco
4-Hydroxytamoxifen, analytical standard, (E) and (Z) isomers (50:50)
Sigma-Aldrich
Monoclonal ANTI-FLAG® M2 antibody produced in mouse, 1 mg/mL, clone M2, affinity isolated antibody, buffered aqueous solution (50% glycerol, 10 mM sodium phosphate, and 150 mM NaCl, pH 7.4)